<DOC>
	<DOCNO>NCT00005605</DOCNO>
	<brief_summary>RATIONALE : Tamoxifen may able increase bone density decrease cholesterol woman undergo chemotherapy breast cancer . PURPOSE : Clinical trial study effectiveness tamoxifen prevent bone loss heart disease cause chemotherapy treatment premenopausal woman stage I stage II breast cancer .</brief_summary>
	<brief_title>Tamoxifen Prevent Bone Loss Heart Disease Premenopausal Women Receiving Chemotherapy Stage I Stage II Breast Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Compare bone density femoral neck lumbar spine cholesterol level premenopausal woman stage I II breast cancer treat adjuvant chemotherapy without tamoxifen . - Collect information regard breast cancer risk factor , treatment , pathology , diet , activity level , weight , smoke patient . OUTLINE : Patients stratify accord type treatment ( adjuvant chemotherapy plus tamoxifen v adjuvant chemotherapy alone ) . Patients receive adjuvant chemotherapy without oral tamoxifen discretion treat physician . Prior start chemotherapy , patient undergo blood draw measure baseline level follicle-stimulating hormone , estradiol , total cholesterol , high-density lipoprotein , low-density lipoprotein . Patients undergo baseline bone densitometry femoral neck lumbar spine ass bone density prior start chemotherapy within 30 day first drug treatment . Laboratory study bone densitometry repeat year 1 2 . A comparison make study finding baseline year 1 2 . PROJECTED ACCRUAL : A total 80 patient ( 40 per stratum ) accrue study .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Tamoxifen</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically proven stage I II breast cancer Must schedule receive adjuvant chemotherapy without tamoxifen Hormone receptor status : Not specify PATIENT CHARACTERISTICS : Age : 35 50 Sex : Female Menopausal status : Premenopausal folliclestimulating hormone estradiol level Performance status : Not specify Life expectancy : Not specify Hematopoietic : Not specify Hepatic : Not specify Renal : Not specify Other : Not pregnant PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : See Disease Characteristics Endocrine therapy : See Disease characteristic Radiotherapy : Not specify Surgery : Not specify</criteria>
	<gender>Female</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>osteoporosis</keyword>
	<keyword>stage I breast cancer</keyword>
	<keyword>stage II breast cancer</keyword>
</DOC>